6.7100
29-十一月-24 12:30:00
15 分钟延时
股票
+0.1700
+2.60%
今日范围
6.5000 - 6.7500
ISIN
N/A
来源
NYSE
Annovis Bio Announces Issuance of U.S. Patent Covering the Use of Lead Drug Candidate, Buntanetap, for Prevention or Treatment of Disease States Due to Metal Dis-Homeostasis in Healthy or Sick Humans
27 4月 2023 06:00:00 条件 Nasdaq GlobeNewswire
Annovis Bio, Inc. to present at the Q1 Virtual Investor Summit
11 3月 2021 06:05:00 条件 Nasdaq GlobeNewswire
Annovis Bio to Present at the BIO CEO & Investor Digital Conference
16 2月 2021 05:45:00 条件 Nasdaq GlobeNewswire